Table 3.
n | Females | Males | p values5 | ||||||
---|---|---|---|---|---|---|---|---|---|
Cluster 1 ‘Inactive’ | Cluster 2 ‘Avoiders’ | Cluster 3 ‘Active’ |
Cluster 1 ‘Inactive’ |
Cluster 2 ‘Avoiders’ |
Cluster 3 ‘Active’ |
Cluster | Sex | Cluster × Sex | |
36 | 13 | 9 | 22 | 11 | 29 | ||||
Behavioral traits2 | |||||||||
Time lying | 0.58 ± 0.03a | 0.50 ± 0.04ab | 0.45 ± 0.04b | 0.54 ± 0.03ab | 0.58 ± 0.04ab | 0.54 ± 0.03ab | 0.09 | 0.08 | 0.03 |
Time standing | 0.23 ± 0.06a | 0.32 ± 0.06b | 0.36 ± 0.06b | 0.25 ± 0.06ab | 0.25 ± 0.06ab | 0.30 ± 0.06ab | < 0.001 | 0.02 | 0.02 |
Time ingesting | 0.02 ± 0.003 | 0.02 ± 0.004 | 0.02 ± 0.005 | 0.01 ± 0.004 | 0.01 ± 0.005 | 0.02 ± 0.003 | 0.13 | 0.11 | 0.79 |
Time suckling | 0.15 ± 0.02 | 0.14 ± 0.02 | 0.12 ± 0.03 | 0.15 ± 0.02 | 0.15 ± 0.03 | 0.17 ± 0.02 | 0.77 | 0.02 | 0.10 |
Production traits | |||||||||
Weight (kg) | 7.2 ± 2.9 | 7.6 ± 3.0 | 9.6 ± 3.0 | 7.5 ± 2.9 | 8.5 ± 3.0 | 8.4 ± 2.9 | < 0.001 | 0.95 | 0.08 |
ADG3 (g/d) | 211 ± 49 | 237 ± 52 | 276 ± 54 | 207 ± 50 | 247 ± 53 | 251 ± 50 | 0.006 | 0.66 | 0.69 |
Blood parameters | |||||||||
5-HT (µmol/L PRP4) | 14.0 ± 4.5 | 14.8 ± 4.9 | 11.7 ± 5.2 | 18.6 ± 4.7 | 15.2 ± 5.0 | 15.3 ± 4.6 | 0.35 | 0.10 | 0.60 |
Haptoglobin (mg/mL) | 2.3 ± 0.77 | 1.2 ± 0.84 | 1.4 ± 0.90 | 2.4 ± 0.80 | 2.5 ± 0.86 | 1.2 ± 0.78 | 0.02 | 0.22 | 0.19 |
dROM (CARRU) | 914 ± 43 | 842 ± 61 | 796 ± 74 | 902 ± 51 | 995 ± 66 | 868 ± 47 | 0.22 | 0.09 | 0.24 |
FRAP (µg/mL) | 67 ± 3.6 | 69 ± 4.2 | 68 ± 4.7 | 66 ± 3.9 | 67 ± 4.5 | 68 ± 3.7 | 0.69 | 0.69 | 0.84 |
1LS-Means ± S.E.M.;
2Proportion of total observation time;
3ADG, average daily gain;
4PRP, platelet-rich plasma;
5Letters indicate differences between groups as estimated by post-hoc test with Tukey adjustment for comparing multiple groups (p < 0.05).